OTC Markets EXMKT - Delayed Quote USD

Rennova Health, Inc. (RNVA)

0.0001
0.0000
(0.00%)
At close: May 7 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
18,685.8450
18,685.8450
13,036.1720
3,223.8960
7,200.1200
Cost of Revenue
7,574.5480
7,574.5480
6,767.9210
5,292.4300
11,783.5260
Gross Profit
11,111.2970
11,111.2970
6,268.2510
-2,068.5340
-4,583.4060
Operating Expense
9,745.5590
9,745.5590
7,686.7760
8,151.1640
12,361.8920
Operating Income
1,365.7380
1,365.7380
-1,418.5250
-10,219.6980
-16,945.2980
Net Non Operating Interest Income Expense
-1,452.8230
-1,452.8230
-2,257.5440
-3,185.8280
-9,840.7240
Other Income Expense
-226.9590
-226.9590
639.0190
8,312.6830
7,834.1350
Pretax Income
-314.0440
-314.0440
-3,037.0500
-5,092.8430
-18,951.8870
Tax Provision
239.8340
239.8340
312.8490
179.5300
-1,308.1800
Net Income Common Stockholders
-7,729.1610
-7,729.1610
-334,169.4240
-500,871.8500
-281,594.4920
Diluted NI Available to Com Stockholders
-7,729.1610
-7,729.1610
-334,169.4240
-500,871.8500
-281,594.4920
Basic EPS
0.05
0.00
-0.03
-913.37
-93.86M
Diluted EPS
0.05
0.00
-0.03
-913.37
-93.86M
Basic Average Shares
29,671,259.3000
32,825,519.5170
9,992,238.4680
548.3770
0.0030
Diluted Average Shares
384,187,214.7000
32,825,519.5170
9,992,238.4680
548.3770
0.0030
Total Operating Income as Reported
--
--
-1,409.5340
-12,520.5240
-17,195.2980
Total Expenses
17,320.1070
17,320.1070
14,454.6970
13,443.5940
24,145.4180
Net Income from Continuing & Discontinued Operation
-7,729.1610
-7,729.1610
-3,293.0550
5,605.1570
-18,339.7740
Normalized Income
555.0983
555.0983
-3,512.3751
-7,415.9735
-19,936.4351
Interest Expense
1,452.8230
1,452.8230
2,257.5440
3,185.8280
9,840.7240
Net Interest Income
-1,452.8230
-1,452.8230
-2,257.5440
-3,185.8280
-9,840.7240
EBIT
1,138.7790
1,138.7790
-779.5060
-1,907.0150
-9,111.1630
EBITDA
1,449.3070
1,449.3070
-310.1350
-1,263.4640
-8,410.1700
Reconciled Cost of Revenue
7,574.5480
7,574.5480
6,767.9210
5,292.4300
11,783.5260
Reconciled Depreciation
310.5280
310.5280
469.3710
643.5510
700.9930
Net Income from Continuing Operation Net Minority Interest
-534.0850
-534.0850
-3,349.8990
-5,272.3730
-17,643.7070
Total Unusual Items Excluding Goodwill
-1,378.7130
-1,378.7130
205.6660
2,936.4390
2,462.6510
Total Unusual Items
-1,378.7130
-1,378.7130
205.6660
2,936.4390
2,462.6510
Normalized EBITDA
2,828.0200
2,828.0200
-515.8010
-4,199.9030
-10,872.8210
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0001
Tax Effect of Unusual Items
-289.5297
-289.5297
43.1899
792.8385
169.9229
12/31/2020 - 10/19/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SLDX Stella Diagnostics, Inc.
0.0490
0.00%
 
OPK.TA OPKO Health, Inc.
447.10
-0.38%
 
DIA.WA Diagnostyka S.A.
170.00
0.00%
 
RSHN RushNet, Inc.
0.0002
0.00%
 
DAP.F Danaher Corporation
175.46
+4.08%
 
IDXG Interpace Biosciences, Inc.
0.6450
-7.86%
 
PRE Prenetics Global Limited
5.19
+1.17%
 
STRR Star Equity Holdings, Inc.
2.3494
-0.03%
 
ILU.MU Illumina Inc
70.39
+7.53%
 
BIOPOR.CO BioPorto A/S
1.5220
-0.52%